Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) Fax / Téléc : (902)

Similar documents
Pharmacy Consultant, PEI Drug Programs Date : September 8, 2009 Tel / Tél : (902) Fax / Téléc : (902)

PEI Drug Programs. Issue October, 2006

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs

BULLETIN # 74. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 17, 2013

UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

Product Selection Committee / Comité de sélection des produits

SASKATCHEWAN FORMULARY BULLETIN. Update to the 60th Edition of the Saskatchewan Formulary

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY

Archived Content. This content was archived on June 24, 2013.

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY

Ontario Drug Benefit Formulary/ Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

ANNOUNCEMENT. Dear Valued Customer:

Product Selection Committee / Comité de sélection des produits

Ontario Drug Benefit Formulary/Comparative Drug Index

BULLETIN # 78. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2014

BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015

BULLETIN # 73. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2013

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY

Updates to the Alberta Drug Benefit List. Effective February 1, 2018

UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES

UPDATE E Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective December 23, 2008 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 57th EDITION OF THE SASKATCHEWAN FORMULARY

Archived Content. This content was archived on June 24, 2013.

Updates to the Alberta Health and Wellness Drug Benefit List

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES

DT Description Price Category Price change

BULLETIN # 72. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 18, 2013

Summary of Changes to the Alberta Health and Wellness Drug Benefit List

Alaska Medicaid 90 Day** Generic Prescription Medication List

NIHB NEWSLETTER. Ontario Pharmacy Providers Winter 2010 PROVIDER CLAIMS PROCESSING CALL CENTRE

UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES

BULLETIN # 52. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on September 14, 2006.

NB Drug Plans Formulary Update

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

BULLETIN # 98. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 19, 2018

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

NBPDP Formulary Update

Updates to the Alberta Drug Benefit List. Effective November 1, 2018

NB Drug Plans Formulary Update

Updates to the Alberta Drug Benefit List. Effective September 1, 2018

UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES

Palliative Coverage Drug Benefit Supplement

Palliative Care Drug Benefit Supplement

Archived Content. This content was archived on June 24, 2013.

Ontario Drug Benefit Formulary/Comparative Drug Index

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %

BULLETIN # 101. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 18, 2018

NB Drug Plans Formulary Update

BULLETIN # 89. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 20, 2016

BULLETIN # 79. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 16, 2014

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.

Ontario Drug Benefit Formulary/Comparative Drug Index

New Exception Status Benefits

Ontario Drug Benefit Formulary/Comparative Drug Index

SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary

UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES

Updates to the Alberta Drug Benefit List. Effective May 1, 2018

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 54th EDITION

BULLETIN # 65. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 14, 2010.

Ontario Drug Benefit Formulary/Comparative Drug Index

UPDATE C Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective November 04, 2008 SUMMARY OF CHANGES

Updates to the Alberta Drug Benefit List. Effective July 1, 2018

Ontario Drug Benefit Formulary/Comparative Drug Index

BULLETIN # 80. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 19, 2015

DT Description Price Category Price change Percentage

Ontario Drug Benefit Formulary/Comparative Drug Index

Professionalism & Service with Great Prices

Updates to the Alberta Drug Benefit List. Effective October 1, 2017

Ontario Drug Benefit Formulary/Comparative Drug Index

Therapeutic Substitution Service - Proton Pump Inhibitors (PPIs)

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

BULLETIN # 70. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 21, 2013

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

AMANTADINE 50 MG/5 ML SYRUP ACYCLOVIR 200 MG CAPSULES ACYCLOVIR 400 MG TABLETS ACYCLOVIR 800 MG TABLETS 30 90

BULLETIN # 90. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 25, 2017

P.E.I. Pharmacare Formulary

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

Ontario Drug Benefit Formulary/Comparative Drug Index

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN 52nd Edition

UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES

New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March 2016

Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN 55th EDITION

Pharma X Consultancy Inc. Inventory List

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 54th EDITION

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017

Ontario Drug Benefit Formulary/Comparative Drug Index

Drug Regimen Optimization

Updates to the Alberta Drug Benefit List. Effective June 1, 2018

Updates to the Alberta Drug Benefit List. Effective December 1, 2018

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

Transcription:

DRAFT To / Destinataire : All Retail Pharmacists and Staff From / Expéditeur : Faye Campbell Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) 368-6338 Fax / Téléc : (902) 368-4905 Subject / Objet : December 2009 Update to the Interchangeable / Maximum Allowable Cost List E-mail / Courriel : fecampbell@gov.pe.ca The December 2009 update to the PEI Drug Programs Interchangeable / Maximum Allowable Cost (MAC) List has been st published. Changes in interchangeability will come into effect on 21 December 2009. Changes in pricing related to the th addition of new interchangeable/mac categories will come into effect on 4 January 2009. Adobe Acrobat (pdf) and Excel versions of the complete list can be downloaded from the Government website at: www.gov.pe.ca/sss/. All product availability and pricing has been confirmed with manufacturers prior to publication of this update. Please contact the Pharmacy Services Office at 368-4947 (Charlottetown) or 1-877-577-3737 (toll-free in PEI) if you are unable to access a copy of the list online. Please note that the Maximum Allowable Cost List also contains products that although not listed in the Drug Programs Formulary but may be available through the Special Authorization (Exceptional Drug Request) Process. Refer to the Formulary to determine coverage of products under specific drug programs. In addition, some of the Interchangeable / MAC Categories are only available through the Palliative Home Care Drug Pilot Project. NEW INTERCHANGEABLE / MAC CATEGORIES No new interchangeable categories PRODUCTS ADDED TO THE INTERCHANGEABLE / MAC LIST The following products have been added to existing interchangeable categories. CO-OLANZAPINE ODT 5 MG TABLETS 02327562 CO-OLANZAPINE ODT 10 MG TABLETS 02327570 CO-OLANZAPINE ODT 15 MG TABLETS 02327589 December 2009 MAC List Update Page- 1

NOVO-LANSOPRAZOLE DR 15 MG CAPSULES 02280515 NOVO-LANSPPRAZOLE DR 30 MG CAPSULES 02280523 PHL-ALENDRONATE-FC 70 MG TABLETS 02299712 PHL-AMLODIPINE 5 MG TABLETS 02326779 PHL-AMLODIPINE 10 MG TABLETS 02326787 PHL-ATENOLOL 25 MG TABLETS 02247182 PHL-ATENOLOL 50 MG TABLETS 02238316 PHL-ATENOLOL 100 MG TABLETS 02238318 PHL-AZITHROMYCON 250 MG TABLETS 02278588 PHL-BACLOFEN 10 MG TABLETS 02236963 PHL-BACLOFEN 20 MG TABLETS 02236964 PHL-CARVEDILOL 3.125 MG TABLETS 02248452 PHL-CARVEDILOL 6.25 MG TABLETS 02248753 PHL-CARVEDILOL 12.5 MG TABLETS 02248754 PHL-CARVEDILOL 25 MG TABLETS 02248753 PHL-CITALOPRAM 10 MG TABLETS 02273543 PHL-CITALOPRAM 20 MG TABLETS 02248944 PHL-CITALOPRAM 40 MG TABLETS 02248945 PHL-CLONAZEPAM 0.5 MG TABLETS 02236948 PHL-CLONAZEPAM 1 MG TABLETS 02145235 PHL-CLONAZEPAM 2 MG TABLETS 02145243 PHL-CYCLOBENZAPRINE 10 MG TABLETS 02249359 PHL-FLUOXETINE 10 MG CAPSULES 02223481 PHL-FLUOXETINE 20 MG CAPSULES 02223503 PHL-GABAPENTIN 100 MG CAPSULES 02246314 PHL-GABAPENTIN 300 MG CAPSULES 02246315 PHL-GABAPENTIN 400 MG CAPSULES 02246316 PHL-MIRTAZAPINE 15 MG TABLETS 02281732 PHL-MIRTAZAPINE 30 MG TABLETS 02252279 PHL-ONDANSETRON 4 MG TABLETS 02278618 PHL-ONDANSETRON 8 MG TABLETS 02278626 PHL-PANTOPRAZOLE 40 MG TABLETS 02309866 PHL-PAROXETINE 20 MG TABLETS 02248451 PHL-PAROXETINE 30 MG TABLETS 02248452 PHL-PIOGLITAZONE 15 MG TABLETS 02307669 PHL-PIOGLITAZONE 30 MG TABLETS 02307677 PHL-PIOGLITAZONE 45 MG TABLETS 02307723 PHL-PRAVASTATIN 10 MG TABLETS 02249766 PHL-PRAVASTATIN 20 MG TABLETS 02249774 PHL-PRAVASTATIN 40 MG TABLETS 02249782 PHL-RISPERIDONE 0.25 MG TABLETS 02258439 PHL-RISPERIDONE 0.5 MG TABLETS 02258447 December 2009 MAC List Update Page- 2

PHL-RISPERIDONE 1 MG TABLETS 02258455 PHL-RISPERIDONE 2 MG TABLETS 02258463 PHL-RISPERIDONE 3 MG TABLETS 02258471 PHL-RISPERIDONE 4 MG TABLETS 02258498 PHL-SERTRALINE 25 MG CAPSULES 02245824 PHL-SERTRALINE 50 MG CAPSULES 02245825 PHL-SERTRALINE 100 MG CAPSULES 02245826 PHL-SIMVASTATIN 5 MG TABLETS 02281546 PHL-SIMVASTATIN 10 MG TABLETS 02281554 PHL-SIMVASTATIN 20 MG TABLETS 02281562 PHL-SIMVASTATIN 40 MG TABLETS 02281570 PHL-SIMVASTATIN 80 MG TABLETS 02281589 PHL-TOPIRAMATE 25 MG TABLETS 02271184 PHL-TOPIRAMATE 100 MG TABLETS 02271192 PHL-TOPIRAMATE 200 MG TABLETS 02271206 PHL-ZOPICLONE 5 MG TABLETS 02294052 PHL-ZOPICLONE 7.5 MG TABLETS 02294060 RAN-FENTAYL MTX PATCHES 12 UG/HR 02330105 RAN-FENTAYL MTX PATCHES 25 UG/HR 02330113 RAN-FENTAYL MTX PATCHES 50 UG/HR 02330121 RAN-FENTAYL MTX PATCHES 75 UG/HR 02330148 RAN-FENTAYL MTX PATCHES 100 UG/HR 02330156 The following reimbursement prices have changed. CHANGES TO MAC PRICES AZITHROMYCIN 02212021 ZITHROMAX PFI 3.2634 250MG TABLET 02247423 APO-AZITHROMYCIN APX 02255340 CO AZITHROMYCIN COB 02261634 PMS-AZITHROMYCIN PMS 02265826 SANDOZ AZITHROMYCIN SDZ 02267845 NOVO-AZITHROMYCIN NOP 02275287 RATIO-AZITHROMYCIN RPH 02278359 GEN-AZITHROMYCIN GPM 02278588 PHL-AZITHROMYCIN PHL CETIRIZINE 02223554 REACTINE PFI 0.4287 10MG TABLET 02231603 APO-CETIRIZINE APX OLANZAPINE 02229250 ZYPREXA LIL 1.0154 2.5MG TABLET 02276712 NOVO-OLANZAPINE NOP 02281791 APO-OLANZAPINE APO 02303116 PMS-OLANZAPINE PMS 02325659 CO-OLANZAPINE COB December 2009 MAC List Update Page- 3

OLANZAPINE 02229269 ZYPREXA LIL 2.0308 5MG TABLET 02276720 NOVO-OLANZAPINE NOP 02281805 APO-OLANZAPINE APO 02303159 PMS-OLANZAPINE PMS 02325667 CO-OLANZAPINE COB OLANZAPINE 02229277 ZYPREXA LIL 3.0463 7.5MG TABLET 02276739 NOVO-OLANZAPINE NOP 28881813 APO-OLANZAPINE APO 02303167 PMS-OLANZAPINE PMS 02325675 CO-OLANZAPINE COB OLANZAPINE 02229285 ZYPREXA LIL 4.0617 10MG TABLET 02276747 NOVO-OLANZAPINE NOP 02281821 APO-OLANZAPINE APO 02303175 PMS-OLANZAPINE PMS 02325683 CO-OLANZAPINE COB OLANZAPINE 02238850 ZYPREXA LIL 6.0924 15MG TABLET 02276755 NOVO-OLANZAPINE NOP 02281848 APO-OLANZAPINE APO 02303183 PMS-OLANZAPINE PMS 02325691 CO-OLANZAPINE COB ONDANSETRON HCL 02213575 ZOFRAN GSK 12.0924 8MG TABLET 02258196 PMS-ONDANSETRON PMS 02264064 NOVO-ONDANSETRON NOP 02274329 SANDOZ ONDANSETRON SDZ 02278537 RATIO-ONDANSETRON RPH 02278626 PHL-ONDANSETRON PHL 02288192 APO-ONDANSETRON APX 02296357 CO ONDANSETRON COB 02297876 GEN-ONDANSETRON GPM 02305267 MINT-ONDANSETRON MNT 02306220 ODANSETRON-ODAN ODN 02312255 RAN-ONDANSETRON RAN 02313693 JAMP-ONDANSETRON JPC No deleted categories at this time. DELETED INTERCHANGEABLE / MAC CATEGORIES December 2009 MAC List Update Page- 4

DISCONTINUED PRODUCTS The following products have been removed from the Maximum Allowable Cost List. These products will not appear in the next publication of the Drug Programs Formulary, but will remain as benefits for the next twelve months. CO-GLIMEPIRIDE 1 MG TABLETS 02274248 CO-GLIMEPIRIDE 2 MG TABLETS 02274256 CO-GLIMEPIRIDE 4 MG TABLETS 02274272 MOS CONCENTRATE 20MG/ML 00632481 PMS-MEFENAMIC ACID 250 MG CAPSULES 02231208 ZADITEN 1 MG TABLETS 00577308 No changes CHANGE IN MANUFACTURER IMPORTANT NOTICES The PEI Drug Programs Management and Staff would like to wish you a very Merry Christmas! December 2009 MAC List Update Page- 5